Key takeaways
No shortening of term for response in appeal proceedings due to filing of grounds of appeal prior to end of term or due to contention on a purely legal issue
The arguments that an appeal concerns purely legal issues, the appellant seeks patent protection as soon as possible and the fact that the appellant did not make use of the entire time period within which it could have lodged its statement of grounds of appeal are not sufficient to justify that the time period for the respondents’ statement of response in appeal proceedings concerning an application for a preliminary injunction is shortened.
Division
CoA Luxembourg
UPC number
UPC_CoA_405/2024
APL_40553/2024
App_43889/2024
Type of proceedings
Appeal proceedings, Proceedings on provisional measures
Parties
Alexion Pharmaceuticals, Inc.
Amgen Technology (Ireland) Unlimited Company, Amgen B.V., Amgen GmbH (GER), Amgen GmbH (AUT), Amgen AB, Amgen SAS, Amgen srl, Amgen Biopharmaceutica Lda., Amgen Zdravila DOO
Patent(s)
EP 3 167 888
Jurisdictions
Place jurisdictions
Body of legislation / Rules
Rule 9.3 (b) RoP, Rule 220.1 (c) RoP, Rule 235.2 RoP